HALO logo
halo search icon
Corvus Pharmaceuticals, Inc.

US$12.19

Price Change Indicator
0.69 (6.00%)
Corvus Pharmaceuticals, Inc.
CRVS · NAS

Corvus Pharmaceuticals, Inc.

Start Trading CRVS for Free

US$12.19

Price Arrow0.69 (6.00%)
20/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusEMA 125 BreakdownHALO AllHALO Consensus ValueNear SupportRecent Earnings downgrade
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Corvus Pharmaceuticals, Inc. Overview

CRVS Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Weak

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About CRVS

icon
icon

Telephone

1.650.900.4520

icon

Address

Third Floor, 901 Gateway Boulevard, South San Francisco, CA 94080

Description

Corvus Pharmaceuticals, Inc. engages in the development of immune modulator product candidates with the potential to treat solid cancers, T-cell lymphomas, autoimmune diseases, and infectious diseases. Its product pipeline includes B Cell Activator and Anti-CD73, Adenosine Production Inhibitor Anti-CD73, ITK Inhibitor, A2AR Inhibitor, Anti-CXCR2, and A2BR Inhibitor. The company was founded by Richard A. Miller, Peter A. Thompson, Joseph J. Buggy, and Erik Verner on January 27, 2014 and is headquartered in South San Francisco, CA.

CRVS Price Chart

Key Stats

Market Cap

US$967.04M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 3.38 - 26.95

Trade Value (12mth)

US$5,773,407.00

1 week

-6.58%

1 month

-32.91%

YTD

57.1%

1 year

216.8%

All time high

26.95

Key Fundamentals

EPS 3 yr Growth

-78.20%

EBITDA Margin

0.00%

Operating Cashflow

-$33m

Free Cash Flow Return

-68.90%

ROIC

-32.10%

Interest Coverage

0.00

Quick Ratio

6.20

Other Data

Shares Outstanding (Fully Diluted)

90m

HALO Sector

Healthcare

Next Company Report Date

24-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

CRVS Announcements

Latest Announcements

DateAnnouncements
14 May 26
14 May 26
08 May 26
08 May 26
08 May 26

CRVS Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-0.56-1.02-0.19locklocklock
EPS (Fully Diluted)
 $locklocklocklock-0.56-1.02-0.54locklocklock
Growth
 %locklocklocklock36.6-81.581.1locklocklock
PE
 XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
 XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Corvus Pharmaceuticals, Inc. (CRVS:NAS)?
Halo FAQ
The current share price of Corvus Pharmaceuticals, Inc. (CRVS:NAS) is USD$12.19.
What is the 52-week high share price for Corvus Pharmaceuticals, Inc. (CRVS:NAS)?
Halo FAQ
The 52-week high share price for Corvus Pharmaceuticals, Inc. (CRVS:NAS) is USD$26.95.
What is the 52-week low share price for Corvus Pharmaceuticals, Inc. (CRVS:NAS)?
Halo FAQ
The 52-week low share price for Corvus Pharmaceuticals, Inc. (CRVS:NAS) is USD$3.38.
What is the dividend yield for Corvus Pharmaceuticals, Inc. (CRVS:NAS)?
Halo FAQ
Corvus Pharmaceuticals, Inc. (CRVS:NAS) does not pay a dividend.
What was Corvus Pharmaceuticals, Inc. (CRVS:NAS) last dividend payment?
Halo FAQ
Corvus Pharmaceuticals, Inc. (CRVS:NAS) does not pay a dividend.
What is the franking level for Corvus Pharmaceuticals, Inc. (CRVS:NAS)?
Halo FAQ
Corvus Pharmaceuticals, Inc. (CRVS:NAS) has a franking level of 0.00%.
In which sector is Corvus Pharmaceuticals, Inc. (CRVS:NAS) classified?
Halo FAQ
Corvus Pharmaceuticals, Inc. (CRVS:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial